We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
International medical technology company Ventracor announced the immediate appointment
of Peter Crosby as Chief Operating Officer (COO) to lead the company's strategic
marketing, sales and distribution in Europe and the U.S. Crosby will initially
focus on marketing and sales of the VentrAssist left ventricular assist system,
as well as clinical trials and regulatory approvals.
LAM Pharmaceutical, a biomedical company focused on the development and commercialization
of novel wound healing and transdermal drug delivery systems, announced that
it was achieving excellent results from patient studies currently being conducted
in Ecuador, Panama and Costa Rica. Salvador Ficciella, CEO of aQva Pharmaceuticals,
LAM's distribution partner in the region, stated, "We are receiving exceptionally
Cyberonics announced that the first patient was enrolled in its E20 Phase IV
epilepsy study of patients with less chronic and less resistant medically refractory
partial onset seizures.
Axya Medical, a privately held medical device firm, announced that it has completed
a $6.8 million private placement of preferred equity led by The Vertical Group
of Summit, N.J. The Vertical Group is a venture capital firm that is focused
on the fields of medical technology and biotechnology.
Florida Tech and Kunal Mitra, Florida Tech associate professor of mechanical
and aerospace engineering, have been assigned a U.S. patent for an X-ray delivery
device, which can be used for arterial irradiation following balloon angioplasty.
Advanced Neuromodulation Systems said it received a subpoena from the Department
of Health and Human Services for documents related to the company's sales and
billing practices.
Conor Medsystems announced that the company has initiated
legal proceedings in the High Court of Justice in the UK to revoke Angiotech
Pharmaceutical's patent (No. EP 0 706 376), which relates to stents coated with
paclitaxel and a polymeric carrier.
A clinical trial is underway at the Hospital of the University of Pennsylvania
to study the safety and effectiveness of an endovascular medical device to treat
life-threatening thoracic aortic aneurysms.
Medical device company DISA Vascular has announced European CE Mark approval
and market launch of its ChromoFlex Micro stent system for small coronary vessels,
following CE approval of the large-vessel version, the ChromoFlex, in September
2004.